Letters Varenicline’s adverse events Authors’ reply to Singh and Loke BMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e4033 (Published 12 June 2012) Cite this as: BMJ 2012;344:e4033 Article Related content Metrics Responses Peer review Related articles Research Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis Published: 04 May 2012; BMJ 344 doi:10.1136/bmj.e2856 Letter Flaws in analysis lead to misleading conclusions about varenicline’s safety in smoking cessation Published: 12 June 2012; BMJ 344 doi:10.1136/bmj.e3873 See more Constitutional symptoms in a young person BMJ December 07, 2016, 355 i5781; DOI: https://doi.org/10.1136/bmj.i5781 What it feels like to be an interesting teaching opportunity BMJ December 07, 2016, 355 i6190; DOI: https://doi.org/10.1136/bmj.i6190 Author’s reply to Dangoor and colleagues BMJ December 05, 2016, 355 i6508; DOI: https://doi.org/10.1136/bmj.i6508 Time for guidelines on safety netting? BMJ December 05, 2016, 355 i6411; DOI: https://doi.org/10.1136/bmj.i6411 The BMJ Christmas appeal 2016-7: Orbis, the sight savers BMJ December 01, 2016, 355 i6425; DOI: https://doi.org/10.1136/bmj.i6425
